Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00492102 · ClinicalTrials.gov registry record · Phase 1
Montelukast in Very Low Birthweight Infants
A Phase 1 study of Bronchopulmonary Dysplasia, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT00492102 is a Phase 1 study of Bronchopulmonary Dysplasia that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 9 participants, below the 236-participant average among 29 other Bronchopulmonary Dysplasia trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00492102, a Phase 1 study of Bronchopulmonary Dysplasia, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the pharmacokinetics (PK) of montelukast (Singulair) in very low birth weight (VLBW) infants at risk for developing bronchopulmonary dysplasia (the need for supplemental oxygen). The investigators' long-term hypothesis is that inhibition of leukotriene signaling in the VLBW preterm lung will decrease inflammation, remodeling and the incidence of bronchopulmonary dysplasia (BPD).
Conditions Studied
Interventions
- DRUG Montelukast
Study Locations (1)
Ohio
- Good Samaritan Hospital - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2007-03 |
| Est. Completion | 2011-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00492102
The ClinicalTrials.gov registry entry for NCT00492102 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 236-participant average among 29 other Bronchopulmonary Dysplasia trials with a reported enrollment target (96% lower). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bronchopulmonary Dysplasia appearing as the primary indexed condition, and to 1 intervention - of which Montelukast is the first listed.
NCT00492102 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT00492102 about?
NCT00492102 is a clinical study titled "Montelukast in Very Low Birthweight Infants". The purpose of this study is to determine the pharmacokinetics (PK) of montelukast (Singulair) in very low birth weight (VLBW) infants at risk for developing bronchopulmonary dysplasia (the need for supplemental oxygen). The investigators' long-term hypothesis is that inhibition of leukotriene signa...
What is the current status of trial NCT00492102?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2007-03. Estimated completion is 2011-06.
What conditions does trial NCT00492102 study?
This clinical trial studies the following conditions: Bronchopulmonary Dysplasia.
What interventions are being tested in trial NCT00492102?
The interventions under investigation include: Montelukast (DRUG).
Who is sponsoring clinical trial NCT00492102?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00492102 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bronchopulmonary Dysplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Inhaled Ciclesonide Study in Preterm Infants
RECRUITING · Phase 1
-
Delivery Room CPAP in Extremely Low Birth Weight Infants
COMPLETED · Phase 1
-
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial
RECRUITING · NA
-
Multidimensional Phenotype Classification in Grade 3 Bronchopulmonary Dysplasia
RECRUITING
-
Genesis Electrical Impedance Tomography (EIT): A Preliminary Study
RECRUITING
-
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.